PET contributions to understanding normal and abnormal cardiac perfusion and metabolism

Annals of Biomedical Engineering

Volumn 28, Issue 8, 2000, Pages 922-929

  Schelbert, Heinrich R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; BIOLOGICAL ORGANS; FATTY ACIDS; GLUCOSE; HEMODYNAMICS; METABOLISM; MUSCLE; NONINVASIVE MEDICAL PROCEDURES; OXIDATION; PHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; SUBSTRATES;

CARDIAC PERFUSION; HEART; ISCHEMIA; MYOCARDIUM; OXIDATIVE METABOLISM;

CARDIOLOGY;

FATTY ACID; GLUCOSE;

BLOOD FLOW VELOCITY; CARDIOVASCULAR DISEASE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CORONARY ARTERY BLOOD FLOW; CORONARY BLOOD VESSEL; ENERGY METABOLISM; HEART; HEART MUSCLE; HEART OUTPUT; HUMAN; METABOLISM; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SCINTISCANNING;

BLOOD FLOW VELOCITY; CARDIAC OUTPUT; CARDIOVASCULAR DISEASES; CORONARY CIRCULATION; CORONARY VESSELS; ENERGY METABOLISM; FATTY ACIDS, NONESTERIFIED; GLUCOSE; HEART; HUMANS; MYOCARDIUM; OXYGEN CONSUMPTION; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0034352164     PISSN: 00906964     EISSN: None     Source Type: Journal    
DOI: 10.1114/1.1310216     Document Type: Article

References (43)

1. Araujo, L., A Lammertsma, C. Rhodes, E. McFalls, H. Iida, E. Rechavia, A. Galassi, R. De Silva, T. Jones, and A. Maseri. Noninvasive quantification of regional myocardial blood flow in coronary artery disease with oxygen-15-labeled carbon dioxide inhalation and positron emission tomography. Circulation 83:875-885, 1991.
2. Ausma, J., F. Thonae, G. D. Dispersyn, W. Flameng, J. L. Vanoverschelde, F. C. Ramaekers, and M. Borgers. Dedifferentiated cardiomyocytes from chronic hibernating myocardium are ischemiatolerant. Mol. Cell. Biochem. 186:159-168, 1998.
3. Ballard, F., W. Danforth, S. Nagele, and R. Bing. Myocardial metabolism of fatty acids. J. Clin. Invest. 39:717-723, 1960.
4. Beanlands, R. S., P. J. Hendry, R. G. Masters, R. A. deKemp, K. Woodend, and T. D. Ruddy. Delay in revascularization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging. Circulation 98:II51-II56, 1998.
5. Bergmann, S., M. Shelton, C. Weinheimer, and P. Herrero. Accuracy of quantitative estimates of myocardial blood flow with rubidium-82 and positron emission tomography. J. Nucl. Med. 30:807, 1989.
6. Bing, R. J. The metabolism of the heart. Harvey Lectures :27-70, 1954/1955.
7. Brown, M. A., D. W. Myears, and S. R. Bergmann. Validity of estimates of myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography despite altered patterns of substrate utilization. J. Nucl. Med. 30:187-193, 1989.
8. Chen, C., M. Lijie, D. Linfert, T. Lai, J. Fallon, L. Gillam, D. Waters, and G. Tsongalis. Myocardial cell death and apoptosis in hibernating myocardium. J. Am. Coll. Cardiol. 30:1407-1412, 1997.
9. Czernin, J., P. Müller, S. Chan, R. Brunken, G. Porenta, J. Krivokapich, K. Chen, A. Chan, M. Phelps, and H. Schelbert. Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation 88:62-69, 1993.
10. Czernin, J., and H. R. Schelbert. Non-invasive quantification of myocardial blood flow and flow reserve using dynamic positron emission tomography. Wiener Klinische Wochenschrift 106:478-486, 1994.
11. Depré, C., J.-L. J. Vanoverschelde, J. Melin, M. Borgers, A. Bol, J. Ausma, R. Dion, and W. Wijns. Structural and metabolic correlates of the reversibility of chronic left ventricular ischemic dysfunction in humans. Am. J. Physiol. 268:H1265-H1275, 1995.
12. Elsässer, A., M. Schlepper, W. P. Kleovekorn, W. J. Cai, R. Zimmermann, K. D. Meuller, R. Strasser, S. Kostin, C. Gagel, B. Meunkel, W. Schaper, and J. Schaper. Hibernating myocardium: an incomplete adaptation to ischemia. Circulation 96:2920-2931, 1997.
13. Elsässer, A., M. Schlepper, R. Zimmermann, K. D. Meuller, R. Strasser, W. P. Kleovekorn, and J. Schaper. The extracellular matrix in hibernating myocardium-a significant factor causing structural defects and cardiac dysfunction. Mol. Cell. Biochem. 186:147-158, 1998.
14. Feigl, E., G. Neat, and A. Huang. Interrelations between coronary artery pressure, myocardial metabolism and coronary blood flow. J. Mol. Cell. Cardiol. 22:375-390, 1990.
15. Flameng, W., R. Suy, F. Schwarz, M. Borgers, J. Piessens, F. Thone, H. Van Ermen, and H. De Geest. Ultrastructural correlates of left ventricular contraction abnormalities in patients with chronic ischemic heart disease: determinants of reversible segmental asynergy post-revascularization surgery. Am. Heart J. 102:846-857, 1981.
16. Flameng, W. J., B. Shivalkar, B. Spiessens, A. Maes, J. Nuyts, J. VanHaecke, and L. Mortelmans. PET scan predicts recovery of left ventricular function after coronary artery bypass operation. Ann. of Thoracic Surg. 64:1694-701, 1997.
17. Fragasso, G., S. Chierchia, G. Lucignani, C. Landoni, A. Conversano, M. Gilardi, F. Colombo, C. Rossetti, and F. Fazio. Time dependence of residual tissue viability after myocardial infarction assessed by [18F] fluorodeoxyglucose and positron emission tomography. Am. J. Cardiol. 72:131G-139G, 1993.
18. Holmberg, S., W. Serzysko, and E. Varnauskas. Coronary circulation during heavy exercise in control subjects and patients with coronary heart disease. Acta Med. Scand., Suppl. 190:465-480, 1971.
19. Hutchins, G., M. Schwaiger, K. Rosenspire, J. Krivokapich, H. Schelbert, and D. Kuhl. Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J. Am. Coll. Cardiol. 15:1032-1042, 1990.
20. Keul, J., E. Doll, H. Steim, H. Homburger, H. Kern, and H. Reindell. Uber den Stoffwechsel des menschlichen Herzens. I. Substratversorgung des gesunden Herzens in Ruhe, während und nach körperlicher Arbeit. Pfluegers Arch. Gesamte Physiol. Menschen Tiere 282:1-27, 1965.
21. Krivokapich, J., S. Huang, and H. Schelbert. Response of absolute myocardial blood flow to dobutamine assessed with nitrogen-13 ammonia and dynamic positron emission tomography. J. Am. Coll. Cardiol. 17:379A, 1991.
22. Krivokapich, J., S. C. Huang, and H. R. Schelbert. Assessment of the effects of dobutamine on myocardial blood flow and oxidative metabolism in normal human subjects using nitrogen-13 ammonia and carbon-11 acetate. Am. J. Cardiol. 71:1351-1356, 1993.
23. Krivokapich, J., G. T. Smith, S. C. Huang, E. J. Hoffman, O. Ratib, M. E. Phelps, and H. R. Schelbert. N-13 ammonia myocardial imaging at rest and with exercise in normal volunteers: Quantification of absolute myocardial perfusion with dynamic positron emission tomography. Circulation 80:1328-1337, 1989.
24. Lim, H., J. A. Fallavollita, R. Hard, C. W. Kerr, and J. M. Canty, Jr. Profound apoptosis-mediated regional myocyte loss and compensatory hypertrophy in pigs with hibernating myocardium. Circulation 100:2380-2386, 1999.
25. Lopaschuk, G., and W. Stanley. Glucose metabolism in the ischemic heart. Circulation 95:313-315, 1997.
26. Maes, A., W. Flameng, J. Nuyts, M. Borgers, B. Shivalkar, J. Ausma, G. Bormans, C. Schiepers, M. De Roo, and L. Mortelmans. Histological alterations in chronically hypoperfused myocardium. Correlation with PET findings. Circulation 90:735-745, 1994.
27. Ng, C. K., S. C. Huang, H. R. Schelbert, and D. B. Buxton. Validation of a model for 1-11C acetate as a tracer of cardiac oxidative metabolism. Am. J. Physiol. 266:H1304-H1315, 1994.
28. Nuutila, P., V. A. Koivisto, J. Knuuti, U. Ruotsalainen, M. Tereas, M. Haaparanta, J. Bergman, O. Solin, L. M. Voipio-Pulkki, U. Wegelius, and et al. Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo. J. Clin. Invest. 89:1767-1774, 1992.
29. Opie, L. H. The Heart-Physiology and Metabolism. New York: Raven Press, 1991.
30. Pagano, D., J. N. Townend, W. A. Littler, R. Horton, P. G. Camici, and R. S. Bonser. Coronary artery bypass surgery as treatment for ischemic heart failure: the predictive value of viability assessment with quantitative positron emission tomography for symptomatic and functional outcome. J. Thorac. Cardiovasc. Surg. 115:791-799, 1998.
31. Phelps, M. E., E. J. Hoffman, C. E. Selin, S. C. Huang, G. Robinson, N. MacDonald, H. Schelbert, and D. E. Kuhl. Investigation of [18F] 2-fluoro-2-deoxyglucose for the measure of myocardial glucose metabolism. J. Nucl. Med. 19:1311-1319, 1978.
32. Rahimtoola, S. H. The hibernating myocardium. Am. Heart J. 117:211-221, 1989.
33. Randle, P. J., and P. K. Tubbs. Carbohydrate and fatty acid metabolism. In: Handbook of Physiology, Section 2: The Cardiovascular System, edited by R. M. Berne, N. Sperelakis, and S. R. Geiger. Bethesda: The American Physiological Society, 1979 pp. 805-844.
34. Rubin, P. J., D. S. Lee, V. G. Daavila-Romaan, E. M. Geltman, K. B. Schechtman, S. R. Bergmann, and R. J. Gropler. Superiority of C-11 acetate compared with F-18 fluorodeoxyglucose in predicting myocardial functional recovery by positron emission tomography in patients with acute myocardial infarction. Am. J. Cardiol. 78:1230-1235, 1996.
35. Schelbert, H. R., E. Henze, H. Sochor, R. G. Grossman, S. C. Huang, J. R. Barrio, M. Schwaiger, and M. E. Phelps. Effects of substrate availability on myocardial C-11 palmitate kinetics by positron emission tomography in normal subjects and patients with ventricular dysfunction. Am. Heart J. 111:1055-1064, 1986.
36. Schöder, H., R. Campisi, T. Ohtake, D. Moon, C. Hoh, J. Czernin, and H. Schelbert. Blood Flow-Metabolism Imaging with Positron Emission Tomography in Patients with Diabetes Mellitus for the Assessment of Reversible left Ventricular Contractile Dysfunction. J. Am. Coll. Cardiol. 33:1328-1337, 1999.
37. Schwaiger, M., D. Sun, G. Deeb, N. Nguyen, F. Haas, F. Sebening, and B. FC. Expression of myocardial glucose transporter (GLUT) mRNAs in patients with advanced coronary artery disease (CAD). Circulation 90:I-113, 1994.
38. Schwarz, E., F. Schoendube, S. Kostin, N. Schmiedtke, G. Schulz, U. Buell, B. Messmer, J. Morrison, P. Hanrath, and J. vom Dahl. Prolonged myocardial hibernation exacerbates cardiomyocyte degeneration and impairs recovery of function after revascularization. J. Am. Coll. Cardiol. 31:1018-1026, 1998.
39. Schwarz, E. R., J. Schaper, J. vom Dahl, C. Altehoefer, B. Grohmann, F. Schoendube, F. H. Sheehan, R. Uebis, U. Buell, B. J. Messmer, W. Schaper, and P. Hanrath. Myocyte degeneration and cell death in hibernating human myocardium. J. Am. Coll. Cardiol. 27:1577-1585, 1996.
40. 11C] acetate. J. Nucl. Med. 38:459-466, 1997.
41. Sun, K., J. Czernin, J. Krivokapich, M. Bottcher, Y. K. Lau, M. Chen, G. Maurer, and H. R. Schelbert. Wall motion and flow response to low dose dobutamine in apparently normal myocardium of multivessel CAD patients. J. Nucl. Med. :35, 1994.
42. Tillisch, J., R. Brunken, R. Marshall, M. Schwaiger, M. Mandelkern, M. Phelps, and H. R. Schelbert. Reversibility of cardiac wall motion abnormalities predicted by positron tomography. N. Engl. J. Med. 314:884-888, 1986.
43. Young, L., Y. Renfu, R. Russell, X. Hu, M. Caplan, J. Ren, G. Shulman, and A. Sinusas. Low-flow ischemia leads to translocation of canine heart GLUT-4 and GLUT-1 glucose transporters to the sarcolemma in vivo. Circulation 95:415-422, 1997.